These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29272492)

  • 1. Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases.
    Biagioli M; Mencarelli A; Carino A; Cipriani S; Marchianò S; Fiorucci C; Donini A; Graziosi L; Baldelli F; Distrutti E; Costantino G; Fiorucci S
    Inflamm Bowel Dis; 2017 Dec; 24(1):123-135. PubMed ID: 29272492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
    Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
    Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PepT1-NOD2 signaling pathway aggravates induced colitis in mice.
    Dalmasso G; Nguyen HT; Ingersoll SA; Ayyadurai S; Laroui H; Charania MA; Yan Y; Sitaraman SV; Merlin D
    Gastroenterology; 2011 Oct; 141(4):1334-45. PubMed ID: 21762661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SYK-CARD9 Signaling Axis Promotes Gut Fungi-Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer.
    Malik A; Sharma D; Malireddi RKS; Guy CS; Chang TC; Olsen SR; Neale G; Vogel P; Kanneganti TD
    Immunity; 2018 Sep; 49(3):515-530.e5. PubMed ID: 30231985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
    Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
    Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
    Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
    Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmuscle Myosin Heavy Chain IIA Recognizes Sialic Acids on Sialylated RNA Viruses To Suppress Proinflammatory Responses via the DAP12-Syk Pathway.
    Liu Y; Li R; Chen XX; Zhi Y; Deng R; Zhou EM; Qiao S; Zhang G
    mBio; 2019 May; 10(3):. PubMed ID: 31064828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
    Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
    Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional Regulation of Circadian Disturbance and Inflammation in Inflammatory Bowel Disease.
    Liu X; Yu R; Zhu L; Hou X; Zou K
    Inflamm Bowel Dis; 2017 Oct; 23(10):1741-1751. PubMed ID: 28902123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL4-mediated targeting of spleen tyrosine kinase (Syk) inhibitor using nanoparticles alleviates inflammatory bowel disease.
    Gong W; Yu J; Zheng T; Liu P; Zhao F; Liu J; Hong Z; Ren H; Gu G; Wang G; Wu X; Zhao Y; Ren J
    Clin Transl Med; 2021 Feb; 11(2):e339. PubMed ID: 33634985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling identifies mechanisms of protection to recurrent trinitrobenzene sulfonic acid colitis mediated by probiotics.
    Mariman R; Kremer B; van Erk M; Lagerweij T; Koning F; Nagelkerken L
    Inflamm Bowel Dis; 2012 Aug; 18(8):1424-33. PubMed ID: 22162025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
    Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
    Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of metallothioneins as danger signals in the pathogenesis of colitis.
    Devisscher L; Hindryckx P; Lynes MA; Waeytens A; Cuvelier C; De Vos F; Vanhove C; Vos MD; Laukens D
    J Pathol; 2014 May; 233(1):89-100. PubMed ID: 24452846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
    Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
    J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSS-induced inflammation in the colon drives a proinflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod.
    Talley S; Valiauga R; Anderson L; Cannon AR; Choudhry MA; Campbell EM
    J Neuroinflammation; 2021 Nov; 18(1):263. PubMed ID: 34758843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterocyte dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin expression in inflammatory bowel disease.
    Zeng JQ; Xu CD; Zhou T; Wu J; Lin K; Liu W; Wang XQ
    World J Gastroenterol; 2015 Jan; 21(1):187-95. PubMed ID: 25574091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fermented barley and soybean (BS) mixture enhances intestinal barrier function in dextran sulfate sodium (DSS)-induced colitis mouse model.
    Woo JK; Choi S; Kang JH; Kim DE; Hurh BS; Jeon JE; Kim SY; Oh SH
    BMC Complement Altern Med; 2016 Dec; 16(1):498. PubMed ID: 27912750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.